Call for Papers

Article List

Editorial [Hot Topic: Alzheimerss Disease, Dementia and Cognitive Decline (Executive Editors: J.E. Starrett, Jr. and G.S. Poindexter)]
[ Vol. 11 , Issue. 26 ]
Author(s): J. E. Starrett, Jr. and G. S. Poindexter
Pages: 3327-3327 (1)
Phosphodiesterase Inhibitors for Cognitive Enhancement
[ Vol. 11 , Issue. 26 ]
Author(s): G. M. Rose, A. Hopper, M. De Vivo and A. Tehim
Pages: 3329-3334 (6)
The Dualistic Nature of Immune Modulation In Alzheimers Disease: Lessons from the Transgenic Models
[ Vol. 11 , Issue. 26 ]
Author(s): R. B. Nelson
Pages: 3335-3352 (18)
Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimers Disease
[ Vol. 11 , Issue. 26 ]
Author(s): J. W. Clader and Y. Wang
Pages: 3353-3361 (9)
γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease
[ Vol. 11 , Issue. 26 ]
Author(s): I. Churcher and D. Beher
Pages: 3363-3382 (20)
Progress in the Discovery of BACE Inhibitors
[ Vol. 11 , Issue. 26 ]
Author(s): L. A. Thompson, J. J. Bronson and F. C. Zusi
Pages: 3383-3404 (22)
RNA Interference-Based Gene Silencing in Mice: The Development of a Novel Therapeutical Strategy
[ Vol. 11 , Issue. 26 ]
Author(s): B. Spankuch and K. Strebhardt
Pages: 3405-3419 (15)
Participation of the Cannabinoid System in the Regulation of Emotional- Like Behaviour
[ Vol. 11 , Issue. 26 ]
Author(s): O. Valverde
Pages: 3421-3429 (9)
Pharmacological Intervention of Cyclooxygenase-2 and 5-Lipoxygenase Pathways. Impact on Inflammation and Cancer
[ Vol. 11 , Issue. 26 ]
Author(s): J. Claria and M. Romano
Pages: 3431-3447 (17)
FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications
[ Vol. 11 , Issue. 26 ]
Author(s): A. S. Advani
Pages: 3449-3457 (9)